Hexarelin, a growth hormone secretagogue, protects the isolated rat heart from ventricular dysfunction produced by exposure to calcium-free medium

This publication has 17 references indexed in Scilit:

• Protectant Activity of Hexarelin or Growth Hormone Against Postischemic Ventricular Dysfunction in Hearts from Aged Rats
  Journal of Cardiovascular Pharmacology, 1998
• A fresh look at reperfusion injury
  Cardiovascular Research, 1998
• Cardiac ischemia and impairment of vascular endothelium function in hearts from GH-deficient rats: Protection by hexarelin
  European Journal of Pharmacology, 1997
• Worsening of ischemic damage in hearts from rats with selective growth hormone deficiency
  European Journal of Pharmacology, 1996
• Hexarelin, a potent GHRP analogue: Interactions with GHRH and clonidine in young and aged dogs
  Peptides, 1995
• GH-releasing activity of hexarelin, a new growth hormone releasing peptide, in infant and adult rats
  Life Sciences, 1994
• Radioimmunoassay for insulin-like growth factor-I: solutions to some potential problems and pitfalls
  Journal of Endocrinology, 1991
• A rise in intracellular sodium would seem to predispose the heart to the calcium paradox
  Journal of Molecular and Cellular Cardiology, 1990
• Tissue concentrations of somatomedin C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action.
  Proceedings of the National Academy of Sciences, 1984
• Myocardial contracture and accumulation of mitochondrial calcium in ischemic rabbit heart
  American Journal of Physiology-Heart and Circulatory Physiology, 1977